Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127250) titled 'Evaluation of the safety, biodistribution and human dosimetry of 68Ga-HT547 PET/CT and 177Lu-HT547 SPECT/CT in the clinical diagnosis of solid tumor patients' on June 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Breast cancer, pancreatic cancer, head and neck cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=325414
P...